Court Revives GSK Lawsuit, Finding Non English Speaking Plaintiffs May Not Have Been Told Drug’s Risks

A California appeals court revived a lawsuit against GlaxoSmithKline in which the plaintiffs claimed the company failed to properly warn non-English speakers about the risks of its antidiabetic drug Avandia (rosiglitazone).
Source: Drug Industry Daily